CTKB Nasdaq

Cytek BioSciences Inc

CTKB 4 | $5.92 -0.67% -0.68% 420K

(0.0% 1d) (-10.4% 1m) (-41.4% 1y) (0.0% 2d) (0.0% 3d) (-1.7% 7d) (-81.42% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 774,478,488
https://www.cytekdev.com/
Sec Filling | Patents | 2021 employees

(United States) Cytek Biosciences, Inc. is a life sciences technology company engaged in the provision of cell analysis tools by leveraging novel technical approaches.

t-cell

add to watch list Paper trade email alert is off

Press-releases

Cytek® Biosciences Names William McCombe Chief Financial Officer
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
CTKB 4 | $5.92 -0.67% -0.68% 420K

Health Technology

| -12.94% | O: -1.03% H: 1.86% C: -0.45%
MS | News | $90.66 0.44% 0.07% 8.1M

Finance

| 3.07% | O: 0.05% H: 1.24% C: 0.48%
cytek financial

Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
Published: 2024-03-07 (Crawled : 23:00) - globenewswire.com
CTKB 4 | $5.92 -0.67% -0.68% 420K

Health Technology

| -17.26% | O: 2.03% H: 1.37% C: -2.47%
cytek cell global solutions

Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
Published: 2024-02-28 (Crawled : 22:00) - globenewswire.com
CTKB 4 | $5.92 -0.67% -0.68% 420K

Health Technology

| -32.27% | O: 1.83% H: 1.91% C: -13.48%
year cytek financial results

Cytek Biosciences to Participate in Upcoming Investor Conferences
Published: 2024-02-07 (Crawled : 21:00) - globenewswire.com
CTKB 4 | $5.92 -0.67% -0.68% 420K

Health Technology

| -24.68% | O: 0.89% H: 5.67% C: 3.15%
cytek

Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Published: 2024-02-07 (Crawled : 21:00) - globenewswire.com
CTKB 4 | $5.92 -0.67% -0.68% 420K

Health Technology

| -24.68% | O: 0.89% H: 5.67% C: 3.15%
report year cytek financial results

Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
Published: 2024-01-17 (Crawled : 23:00) - globenewswire.com
CTKB 4 | $5.92 -0.67% -0.68% 420K

Health Technology

| -25.53% | O: 1.13% H: 8.08% C: 3.36%
cytek agreement

Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
Published: 2024-01-08 (Crawled : 14:00) - globenewswire.com
CTKB 4 | $5.92 -0.67% -0.68% 420K

Health Technology

| -26.64% | O: -0.87% H: 12.87% C: 11.25%
year revenue cytek results

Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-28 (Crawled : 21:00) - globenewswire.com
CTKB 4 | $5.92 -0.67% -0.68% 420K

Health Technology

| -37.35% | O: -0.63% H: 1.06% C: -2.88%
conference cytek

Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
Published: 2023-12-21 (Crawled : 14:00) - globenewswire.com
CTKB 4 | $5.92 -0.67% -0.68% 420K

Health Technology

| -36.55% | O: 0.75% H: 1.6% C: -1.91%
cytek flow

Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
Published: 2023-11-14 (Crawled : 21:00) - globenewswire.com
CTKB 4 | $5.92 -0.67% -0.68% 420K

Health Technology

| 8.23% | O: 0.0% H: 6.86% C: 4.39%
conference cytek

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001415889-24-010714	4	2024-04-11	2024-04-09	Sell	S	400	6008502
0001415889-24-010714	4	2024-04-11	2024-04-09	Sell	S	1500	6008902
0001415889-24-008881	4	2024-03-21	2024-03-20	Sell	M	5464	0
0001415889-24-008881	4	2024-03-21	2024-03-20	Sell	F	2129	3335
0001415889-24-008881	4	2024-03-21	2024-03-20	Buy	M	5464	5464
0001415889-24-008641	4	2024-03-19	2024-03-19	Sell	S	20000	6010402
0001415889-24-008641	4	2024-03-19	2024-03-18	Sell	S	20000	6030402